<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages readOnly="true">en</availableLanguages>
  <rcn>244224</rcn>
  <id>190152193</id>
  <acronym>PARAGON NOVEL VACCINE</acronym>
  <teaser>Immunethep has developed, patented (WO/2015/189422), and successfully undergone preclinical trials for a new breakthrough vaccine (PNV-Paragon Novel Vaccine). It protects against bacterial infections caused by 5 different bacteria: S. aureus, S. pneumoniae, K. pneumoniae, E...</teaser>
  <objective>Immunethep has developed, patented (WO/2015/189422), and successfully undergone preclinical trials for a new breakthrough vaccine (PNV-Paragon Novel Vaccine). It protects against bacterial infections caused by 5 different bacteria: S. aureus, S. pneumoniae, K. pneumoniae, E. coli and GBS. Our innovation relies on the discovery of a virulence and immunosuppressive mechanism common to these pathogens. The bacteria excrete a highly immunosuppressive protein designated as glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which disables the host immune response to infection. PNV works by blocking bacterial GAPDH, while not reacting to human GAPDH, allowing the host immune system to fight infection and eliminate the bacteria. Preclinical trials demonstrated high levels of efficacy against any of the 5 bacteria with an excellent safety profile. PNV is the worlds first vaccine not only to prevent multiple bacterial infections but for all invasive serotypes, including multi-resistant strains.</objective>
  <title>Paragon Novel Vaccine (PNV) an effective protection against all serotypes of five deadly bacteria to eradicate Antimicrobial Resistance (AMR)</title>
  <keywords>Multivalent vaccine for five bacteria (1st worldwide),Preventive immunotherapy for infectious diseases,Antimicrobial Resistance (AMR),Effective against all serotypes (full coverage) ,GAPDH immunosuppressive protein</keywords>
  <totalCost>7400192.5</totalCost>
  <ecMaxContribution>2499999.99</ecMaxContribution>
  <startDate>2023-01-01</startDate>
  <endDate>2025-06-30</endDate>
  <ecSignatureDate>2022-12-21</ecSignatureDate>
  <duration>30</duration>
  <status>SIGNED</status>
  <identifiers>
    <grantDoi>10.3030/190152193</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>true</euroSciVoc>
  </validation>
  <sourceUpdateDate>2022-12-23 17:02:52</sourceUpdateDate>
  <contentCreationDate readOnly="true">2023-03-07 11:08:38</contentCreationDate>
  <contentUpdateDate>2023-04-05 13:27:35</contentUpdateDate>
  <lastUpdateDate readOnly="true">2025-11-03 09:43:37</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <rcn>440864</rcn>
        <id>440864-multipotent-antibacterial-vaccine</id>
        <title>Multipotent antibacterial vaccine</title>
        <contentUpdateDate>2023-07-25 17:58:59</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode readOnly="true">/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode readOnly="true">/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55635</rcn>
        <title>HORIZON-EIC-2022-ACCELERATOR-01</title>
        <identifier>HORIZON-EIC-2022-ACCELERATOR-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55635</rcn>
        <title>HORIZON-EIC-2022-ACCELERATOR-01</title>
        <identifier>HORIZON-EIC-2022-ACCELERATOR-01</identifier>
      </call>
      <organization source="corda" order="1" ecContribution="2499999.99" terminated="false" sme="true" netEcContribution="2499999.99" totalCost="7400192.5" type="coordinator">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1980941</rcn>
        <id>911201123</id>
        <vatNumber>PT510824439</vatNumber>
        <legalName>IMMUNETHEP</legalName>
        <address>
          <street>BIOCANT PARK, NUCLEO 4 LOTE 3</street>
          <city>Cantanhede</city>
          <postalCode>3060 197</postalCode>
          <country>PT</country>
          <geolocation>40.3654887,-8.658317806596092</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <rcn>1471666</rcn>
              <nutsCode>PT192</nutsCode>
            </region>
            <region type="relatedRegion">
              <name>Portugal</name>
              <rcn>427199016</rcn>
              <nutsCode>PT</nutsCode>
              <euCode>PT</euCode>
              <isoCode>PT</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme source="corda" uniqueProgrammePart="true" type="relatedLegalBasis">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705792</rcn>
        <id>HORIZON.3.1</id>
        <code>HORIZON.3.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.1</pga>
        <title>The European Innovation Council (EIC)</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode readOnly="true">/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme source="corda" type="relatedTopic">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>706909</rcn>
        <id>HORIZON_HORIZON-EIC-2022-ACCELERATOROPEN-01</id>
        <code>HORIZON-EIC-2022-ACCELERATOROPEN-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>EIC Accelerator Open</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode readOnly="true">/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456234</code>
              <title>Project financing</title>
              <displayCode readOnly="true">/Project financing</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454386</code>
              <title>Market-creating innovation</title>
              <displayCode readOnly="true">/Market-creating innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450539</code>
              <title>Competitor analysis</title>
              <displayCode readOnly="true">/Competitor analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450029</code>
              <title>Business model innovation</title>
              <displayCode readOnly="true">/Business model innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451698</code>
              <title>Entrepreneurship</title>
              <displayCode readOnly="true">/Entrepreneurship</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453594</code>
              <title>Innovation support services</title>
              <displayCode readOnly="true">/Innovation support services</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43457773</code>
              <title>Spin-off companies</title>
              <displayCode readOnly="true">/Spin-off companies</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456213</code>
              <title>Product innovation</title>
              <displayCode readOnly="true">/Product innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454395</code>
              <title>Marketing strategy</title>
              <displayCode readOnly="true">/Marketing strategy</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453822</code>
              <title>Investment readiness</title>
              <displayCode readOnly="true">/Investment readiness</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452043</code>
              <title>Feasibility analysis</title>
              <displayCode readOnly="true">/Feasibility analysis</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458031</code>
              <title>Sustainable innovation</title>
              <displayCode readOnly="true">/Sustainable innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450041</code>
              <title>Business support services</title>
              <displayCode readOnly="true">/Business support services</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458163</code>
              <title>Technological innovation</title>
              <displayCode readOnly="true">/Technological innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43457365</code>
              <title>SME support</title>
              <displayCode readOnly="true">/SME support</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456414</code>
              <title>Public sector innovation</title>
              <displayCode readOnly="true">/Public sector innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456186</code>
              <title>Private investment</title>
              <displayCode readOnly="true">/Private investment</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453576</code>
              <title>Innovation management</title>
              <displayCode readOnly="true">/Innovation management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450521</code>
              <title>Company valuation</title>
              <displayCode readOnly="true">/Company valuation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452100</code>
              <title><![CDATA[Financial & Investment management]]></title>
              <displayCode readOnly="true"><![CDATA[/Financial & Investment management]]></displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451181</code>
              <title>Due diligence</title>
              <displayCode readOnly="true">/Due diligence</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43451088</code>
              <title>Disruptive innovation</title>
              <displayCode readOnly="true">/Disruptive innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458202</code>
              <title>Technology management</title>
              <displayCode readOnly="true">/Technology management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450026</code>
              <title>Business management</title>
              <displayCode readOnly="true">/Business management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450017</code>
              <title>Business development</title>
              <displayCode readOnly="true">/Business development</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458661</code>
              <title>Venture capital</title>
              <displayCode readOnly="true">/Venture capital</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450014</code>
              <title>Business coaching and mentoring</title>
              <displayCode readOnly="true">/Business coaching and mentoring</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43456756</code>
              <title>Risk management</title>
              <displayCode readOnly="true">/Risk management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453837</code>
              <title>IPR management</title>
              <displayCode readOnly="true">/IPR management</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1092442</rcn>
        <id>190152193_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - PARAGON NOVEL VACCINE (Paragon Novel Vaccine (PNV) an effective protection against all serotypes of five deadly bacteria to eradicate Antimicrobial Resistance (AMR))</title>
        <teaser>Antimicrobial Resistance (AMR) is leading to an uncontrolled rise of superbugs. This worldwide threat kills around 1.27 million people/year and it is estimated to increase by 8-fold until 2050, surpassing 10 million deaths/year. Today AMR costs around $30 billion/year to...</teaser>
        <description>periodic</description>
        <sourceUpdateDate>2024-05-10 05:25:32</sourceUpdateDate>
        <contentUpdateDate>2024-05-10 12:38:00</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode readOnly="true">/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode readOnly="true">/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/341/1035</code>
        <title>bacteriology</title>
        <displayCode readOnly="true">/natural sciences/biological sciences/microbiology/bacteriology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/155/48479582</code>
        <title>immunisation</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/immunology/immunisation</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/653/1439</code>
        <title>vaccines</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drugs/vaccines</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/155/643</code>
        <title>immunotherapy</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/immunology/immunotherapy</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/649/1437</code>
        <title>antibiotic resistance</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/pharmacology and pharmacy/drug resistance/antibiotic resistance</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode readOnly="true">/Digital agenda</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode readOnly="true">/Clean air</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode readOnly="true">/Artificial intelligence</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode readOnly="true">/Climate action</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode readOnly="true">/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages readOnly="true">en</availableLanguages>
        <code>/HORIZON-EIC-ACC-BF</code>
        <title>HORIZON EIC Accelerator Blended Finance</title>
        <description>HORIZON EIC Accelerator Blended Finance</description>
        <displayCode readOnly="true">/HORIZON EIC Accelerator Blended Finance</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode readOnly="true">/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>
